Every Form 4 that AirSculpt Technologies, Inc. (AIRS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AIRS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIRS filings page.
Airsculpt Technologies, Inc. disclosed that an entity associated with major holder Adam T. Feinstein reported an internal share transfer involving its common stock. On May 20, 2026, EBS Aggregator Blocker Holdings, LLC made a distribution in-kind of 5,169,820 shares of common stock for no consideration to Thrivent White Rose Fund XI Equity Direct, L.P., under a prior letter agreement. The filing characterizes this as an "other" type transaction rather than a market purchase or sale. Following the reported transactions, indirect holdings include 4,523,899 shares by Vesey Street Capital Partners Healthcare Fund-A, LP, 14,038,819 shares by VSCP EBS Aggregator, L.P., and 6,591,642 shares by EBS Aggregator Blocker Holdings, LLC.
Higgins Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. director Kenneth Higgins received an award of 100,286 shares of Common Stock in the form of Restricted Stock Units on May 12, 2026. These RSUs vest on the earlier of the first anniversary of grant or the day before the next annual stockholder meeting, subject to his continued service with the company.
Following this award, Higgins directly holds 274,066 shares of Airsculpt Technologies Common Stock as reported in the filing.
Aaron Thomas J reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies director Aaron Thomas reported receiving a grant of 100,286 shares of Common Stock in the form of Restricted Stock Units on May 12, 2026. This is a compensation-related award at no cash cost per share, not an open-market purchase.
The RSUs will vest upon the earlier of the first anniversary of the grant date or the day before the next annual meeting of stockholders, provided he continues serving the company. Following this grant, Thomas holds 276,866 shares directly, showing this is a sizeable but routine equity award for a director.
Airsculpt Technologies, Inc. director Caroline Chu received an equity grant in the form of restricted stock units. She was awarded 100,286 shares of Common Stock on May 12, 2026 as a grant/award acquisition at a stated price of $0.00 per share, reflecting stock-based compensation rather than a market purchase.
According to the filing, her direct holdings increased to 277,066 shares of Common Stock after the award. The RSUs will vest upon the earlier of the first anniversary of the grant date or the day prior to the next annual meeting of stockholders, contingent on her continued service with the company.
Airsculpt Technologies, Inc. insider Jorey Chernett reported an open-market purchase of 40,000 shares of Common Stock at a weighted average price of $2.54 per share. After this transaction, Chernett directly owns 7,053,761 Common Stock shares. The filing notes the shares were bought in multiple trades between $2.52 and $2.56.
The filing also reports the expiration of short call option positions on Airsculpt common stock. Call options on 200,000 underlying shares with a $5.00 exercise price and on 200,400 underlying shares with a $4.00 exercise price expired unexercised because the market price was below the exercise prices, and no consideration was received in connection with these expirations.
Airsculpt Technologies, Inc. major holder Jorey Chernett reported an open-market purchase of 20,000 shares of Common Stock at a weighted average price of $2.60 per share. After this transaction, he directly holds 7,013,761 shares of Airsculpt common stock.
Jashnani Yogesh reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. reported that Chief Executive Officer Yogesh Jashnani received a grant of 238,095 shares of Common Stock in the form of Restricted Stock Units on April 8, 2026 under the company’s 2021 Equity Incentive Plan. These RSUs will vest in three equal annual installments starting on April 8, 2027, contingent on his continued employment. Following this equity award, Jashnani directly holds 696,475 shares of Airsculpt common stock.
Arthur Michael J reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. reported that Chief Financial Officer Arthur Michael J received a grant of 68,027 shares of Common Stock as Restricted Stock Units on April 8, 2026 under the 2021 Equity Incentive Plan. The RSUs will vest in three equal annual installments beginning April 8, 2027, subject to his continued employment. Following this award, he directly holds 215,086 shares of common stock.
WADMAN BRENT R reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. reported that its General Counsel, Brent R. Wadman, received an equity award on April 8, 2026. He was granted 55,272 Restricted Stock Units (RSUs) under the company’s 2021 Equity Incentive Plan, with no cash paid per share.
The RSUs will vest in three equal annual installments beginning on April 8, 2027, as long as he remains employed by the company. Following this grant, he reports ownership of 55,272 shares of common stock directly tied to this award.
Airsculpt Technologies, Inc. ten percent owner Jorey Chernett bought 60,000 shares of common stock in an open-market purchase. The weighted average price was $2.93 per share, with individual trades between $2.91 and $2.94. Following this transaction, Chernett directly holds 6,993,761 shares of Airsculpt common stock.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett reported an open-market purchase of 90,000 shares of common stock at a weighted average price of $2.82 per share. Following this transaction, Chernett directly holds 6,933,761 shares of Airsculpt common stock.
The shares were bought in multiple trades at prices ranging from $2.67 to $3.00 per share, with the reported price representing the rounded weighted average across those individual transactions.
Airsculpt Technologies, Inc. 10% owner Jorey Chernett reported mixed option trades and a stock purchase. On March 23, 2026, he bought 50,000 shares of Airsculpt common stock in the open market at a weighted average price of $2.91 per share, bringing his direct common stock holdings to 6,843,761 shares.
He actively traded call options on Airsculpt that same day. He bought 2,255 call option contracts with a $2.00 strike at $1.30 each, then sold 6,547 of those contracts at a weighted average price of $1.13, ending with none of that series. He also purchased 2,004 call option contracts with a $4.00 strike at $0.50 and 2,000 call option contracts with a $5.00 strike at $0.33, leaving those positions outstanding.
A footnote states the sale of the $2.00 strike call options is a matchable transaction under Section 16(b), and that Chernett has calculated a short-swing profit that he intends to disgorge to Airsculpt.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett reported an open-market purchase of 40,000 shares of common stock at a weighted average price of $2.77 per share. After this transaction, he directly owns 6,793,761 shares, indicating a small increase in an already large position.
Airsculpt Technologies, Inc. Chief Executive Officer Yogesh Jashnani reported a routine tax-withholding transaction related to equity compensation. On the vesting of 97,529 restricted stock units, the company withheld 38,379 shares of common stock at $2.79 per share to cover $107,076.96 of taxes. Following this non‑market disposition, he continues to hold 458,380 shares of common stock directly.
Airsculpt Technologies, Inc. ten percent owner Jorey Chernett purchased common stock in the open market. He bought 77,702 shares at a weighted average price of $2.64 per share, with individual trade prices ranging from $2.49 to $2.70. Following these purchases, he directly owns 6,753,761 shares of common stock.
Airsculpt Technologies, Inc. ten percent owner Jorey Chernett reported an open-market purchase of 83,000 shares of Common Stock at a weighted average price of $2.56 per share on March 17, 2026. Following this trade, Chernett directly owns 6,676,059 shares.
The filing notes the price is a weighted average, with individual purchase prices ranging from $2.43 to $2.70 per share. It also corrects a prior Form 4, which had under‑reported Chernett’s beneficial ownership by 1,000 shares due to a clerical error.
Airsculpt Technologies, Inc. insider Jorey Chernett purchased 105,848 shares of Common Stock in an open-market transaction. The weighted average purchase price was $2.43 per share, with individual trades executed between $1.93 and $2.79 per share. After this transaction, Chernett directly owns 6,592,059 shares.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett reported an open-market purchase of 88,000 shares of Common Stock at a weighted average price of $2.15 per share. The shares were bought in multiple trades between $2.11 and $2.25 per share. Following this transaction, Chernett directly owns 6,486,211 shares, so the new purchase increases an already large position by a relatively small proportion.
Airsculpt Technologies, Inc. major holder Jorey Chernett bought additional shares of the company. On this Form 4, Chernett reported an open-market purchase of 45,600 shares of common stock at a weighted average price of about $2.00 per share, increasing his direct holdings to 6,398,211 shares.
Airsculpt Technologies, Inc. disclosed that 10% owner Jorey Chernett bought a total of 110,000 shares of common stock in open-market purchases. He acquired 80,000 shares at a weighted-average price of $1.71 on March 3 and 30,000 shares at $1.87 on March 4. According to the filing, these were executed in multiple trades at prices ranging from $1.67 to $1.77 and from $1.86 to $1.88. Following these purchases, Chernett directly owns 6,352,611 Airsculpt shares.
AirSculpt Technologies, Inc. CEO Yogesh Jashnani reported a tax-related share withholding tied to restricted stock vesting. On February 3, 2026, 55,098 shares of common stock vested from restricted stock units. The company withheld 24,217 shares, valued at $2.58 per share, to cover $62,484.48 of withholding taxes. After this transaction, Jashnani directly beneficially owned 496,759 shares of AirSculpt Technologies common stock.
AirSculpt Technologies' Chief Financial Officer received new equity awards tied to service and performance. On January 24, 2026, the CFO was granted 147,059 restricted stock units (RSUs) and 147,059 performance stock units (PSUs) at a price of $0 per unit.
The RSUs vest in three equal annual installments starting January 24, 2027, contingent on continued employment. Each PSU represents a right to one share of common stock and will vest based on relative total shareholder return over a three-year period compared with the S&P Health Care Select Industry Index, with outcomes ranging from 0% to 200% of the target award.
AirSculpt Technologies (AIRS) reported an insider equity event by its Chief Executive Officer and director. On 10/27/2025, the first performance milestone in a previously granted award was achieved, triggering the vesting and acquisition of 56,097 shares of common stock via performance stock units (Transaction Code M).
The CEO was originally granted 220,386 PSUs on 01/07/2025 that vest in four tranches tied to stock price goals. The first goal was met when the 60‑day average price reached $7.56 per share, resulting in this vesting. Following the transaction, the reporting person beneficially owned 520,976 common shares, with 164,289 PSUs remaining outstanding.